Brief: Biosergen To Start Human Clinical Trials With BSG005

Biosergen AB

24/08/2021 09:44

Aug 24 (Reuters) - Biosergen AB  BIOSGN.ST :
    * BIOSERGEN'S APPLICATION TO START HUMAN CLINICAL TRIALS
WITH
BSG005 IS APPROVED
    * DUE TO A DELAY IN MANUFACTURING FIRST TRIAL SUBJECTS IS
ASSUMED
TO BE INROLLED EARLY Q4
    * STILL EXPECTS TO BE ABLE TO REPORT TOP LINE RESULTS FROM
TRIAL
BY Q1 2022.

Source text for Eikon:  ID:nWkr5txYyr 
Further company coverage:  BIOSGN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))